BioDuro-Sundia, an Advent International portfolio company, is a trusted, leading contract research, development, and manufacturing organization (CRDMO) with over 27 years of experience. The company provides its biotech and pharmaceutical partners with fully integrated services to support their efforts from target identification through to commercial drug product manufacturing. Based in the US with operations in China, BioDuro-Sundia employs a workforce of 2,500 across 9 global sites in 6 cities. As a prominent provider of contract research, development, and manufacturing outsourcing solutions, the company offers a comprehensive array of scientific services spanning the drug discovery and development continuum. Their precise balance of scientific rigor and flexibility enables fast, informed decision-making, maximising the chances of success at every stage of any project. BioDuro-Sundia collaborates closely with its customers, ensuring an exceptional experience and a constant pursuit of success through a culture of empowerment, respect for diversity, recognition, and cooperation.

Services include:
- 505(b)(2)
- Accelerated Stability Studies
- ADMET
- Analytical Services
- Animal Health
- Animal Model Services
- API Solubilization Technologies
- Assay Development
- Bioanalytical Services
- Bioavailability Studies
- Blending
- cGMP Synthesis
- Raw Materials
- Chemistry (CMC)
- Combinatorial
- Computational
- Medicinal
- Chiral Separations
- R&D
- Chromatography
- Contract Research (CRO)
- Contract Sales
- Manufacturing
- Dissolution Testing
- Distribution
- Clinical Trials
- Documentation Support Services
- Dosage Form Development
- Drug Delivery Devices
- Drug Design
- Contract Development
- Drug Screening
- Encapsulation
- Filling
- Capsule
- Fluid Bed Processing
- Forced Degradation Studies
- Process Development
- Formulation Development
- Controlled Release
- High Throughput Screening
- Hot Melt Extrusion
- In Vitro Testing
- Testing
- IND/NDA Submissions
- Lead Optimization
- Library Synthesis
- Lot Release Testing
- Bioequivalence
- Clinical Trial Materials
- Cytotoxic & High Potency Compounds
- Dose Form
- Non-Sterile
- Generics
- Inhalables
- Liquids
- Nutraceuticals
- Orally Dispersible Tablet
- OTC
- Powders
- Solid Dosage
- Solutions & Suspensions
- Sustained Release
- Tablets
- Clinical Studies
- Metabolic Analysis
- Mixing & Blending
- Mixing and Granulating Equipment
- Nonclinical Research
- Packaging
- Labelling
- Particle Characterization
- Particle Size Analysis
- Particle Size Classification
- Pharmacodynamics
- Pharmacokinetics
- Pharmacology
- Photostability
- Physical Testing
- Pilot-Scale Filling
- Preclinical Study Design
- Preclinical Testing
- Preclinical Testing Formulations
- Preformulation
- Process R&D
- Process Validation Studies
- Project Management
- Quality QA/QC
- R&D Services
- Raw Materials Analysis
- Scale-Up
- Shipping
- Size Reduction
- Spray Drying
- Statistical Analysis
- Storage
- Sustained Release Delivery Systems
- Tablet Coating
- Target Profiling
- Technology Transfer
- Thermogravimetric Analysis
- Validation
- Cleaning Equipment
- Warehousing
- X-Ray Powder Diffraction
- Regulatory Services
- Clinical Dose
- Clinical Packaging
- Containment
- APIs (Active Pharmaceutical Ingredients)
- Non Sterile Dosage
- Biologics
- Finished Dosage Forms

BioDuro-Sundia continues to serve as an essential partner in the pharmaceutical industry, ensuring that clients receive high-quality services tailored to their specific needs. More information can be found at bioduro-sundia.com.